TWD 50.6
(-3.07%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -62.85 Million TWD | 29.13% |
2022 | -82.87 Million TWD | -36.53% |
2021 | -60.7 Million TWD | -25.49% |
2020 | -48.37 Million TWD | -33.25% |
2019 | -36.3 Million TWD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | -2.03 Million TWD | 86.82% |
2024 Q2 | -2.03 Million TWD | 0.0% |
2023 Q4 | -15.47 Million TWD | 0.0% |
2023 Q3 | -15.47 Million TWD | 2.99% |
2023 FY | -58.73 Million TWD | 29.13% |
2023 Q1 | -15.95 Million TWD | 0.68% |
2023 Q2 | -15.95 Million TWD | 0.0% |
2022 FY | -82.87 Million TWD | -36.53% |
2022 Q3 | -16.06 Million TWD | 0.0% |
2022 Q4 | -16.06 Million TWD | 0.0% |
2021 FY | -60.7 Million TWD | -25.49% |
2020 FY | -48.37 Million TWD | -33.25% |
2019 FY | -36.3 Million TWD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
SYN-TECH Chem. & Pharm. Co., Ltd. | 281.85 Million TWD | 122.3% |
Level Biotechnology Inc. | 67.55 Million TWD | 193.044% |
TaiMed Biologics Inc. | -166.23 Million TWD | 62.189% |
GlycoNex Incorporation | -259.86 Million TWD | 75.813% |
GeneReach Biotechnology Corp. | -229.28 Million TWD | 72.587% |
OBI Pharma, Inc. | -2.08 Billion TWD | 96.992% |
Taiwan Advance Bio-Pharmaceutical Inc. | -2.25 Million TWD | -2689.747% |
Genomics BioSci & Tech. Co.,Ltd. | -84.99 Million TWD | 26.05% |
Visgeneer Inc. | -21.15 Million TWD | -197.051% |
Neith Corporation | -48.85 Million TWD | -28.655% |
Lumosa Therapeutics Co., Ltd. | -375.62 Million TWD | 83.267% |
Medigen Vaccine Biologics Corporation | -1.21 Billion TWD | 94.822% |
TaiwanJ Pharmaceuticals Co., Ltd. | -6.61 Million TWD | -850.877% |
Enimmune corporation | -243.47 Million TWD | 74.185% |
TaiRx, Inc. | -214.69 Million TWD | 70.725% |
CHO Pharma, Inc. | -268.99 Million TWD | 76.634% |
BioLASCO Taiwan Co., Ltd. | 63.33 Million TWD | 199.239% |
Sunny Pharmtech Inc. | -72.09 Million TWD | 12.82% |
Ever Supreme Bio Technology Co., Ltd | 337.73 Million TWD | 118.61% |
Feng Chi Biotech Corp. | 24.16 Million TWD | 360.132% |
Lukas Biomedical Inc. | -43.56 Million TWD | -44.291% |
RBC Bioscience Corporation | 14.53 Million TWD | 532.306% |
NaviFUS Corp. | -76.42 Million TWD | 17.76% |
BRIM Biotechnology, Inc. | -694.12 Million TWD | 90.945% |
Shine-On BioMedical Co.,Ltd. | -62.68 Million TWD | -0.271% |
Great Novel Therapeutics Biotech & Medicals | -65.81 Million TWD | 4.508% |
Sagittarius Life Science Corp | -64.37 Million TWD | 2.366% |
Bio Preventive Medicine Corp. | -70.58 Million TWD | 10.95% |
Advagene Biopharma Co., Ltd. | -93.33 Million TWD | 32.659% |
BioGend Therapeutics Co., Ltd. | -176.54 Million TWD | 64.398% |
G&E Herbal Biotechnology Co., Ltd. | 80.68 Million TWD | 177.9% |
Andros Pharmaceuticals Co.,Ltd | -67.69 Million TWD | 7.155% |
Lin BioScience, Inc. | -1.09 Billion TWD | 94.27% |
Anti-Microbial Savior BioteQ Co., Ltd | -56.74 Million TWD | -10.756% |
AP Biosciences Inc | -347.47 Million TWD | 81.912% |
Sunmax Biotechnology Co., Ltd. | 894.79 Million TWD | 107.024% |
Syngen Biotech Co.,Ltd. | 334.08 Million TWD | 118.814% |
EirGenix Inc. | -1.03 Billion TWD | 93.909% |
Pharmosa Biopharm Inc. | -2.82 Million TWD | -2125.673% |
Mycenax Biotech Inc. | -602.1 Million TWD | 89.561% |
SynCore Biotechnology Co.,Ltd | -45.5 Million TWD | -38.132% |
Eusol Biotech Co.,Ltd. | -41.48 Million TWD | -51.519% |
NeoCore Technology Co., Ltd. | -84.94 Million TWD | 26.007% |
VBI | -16.13 Million TWD | -289.617% |
BiOptic Inc. | 44.05 Million TWD | 242.676% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | -93.95 Million TWD | 33.103% |
Sinew Pharma Inc. | -186.25 Million TWD | 66.254% |
Greenyn Biotechnology Co., Ltd | 159.81 Million TWD | 139.328% |
Medigen Biotechnology Corp. | -1.23 Billion TWD | 94.903% |
Intech Biopharm Corporation | -304.39 Million TWD | 79.352% |
Oneness Biotech Co., Ltd. | -1.09 Billion TWD | 94.269% |
TWi Biotechnology, Inc. | -169.55 Million TWD | 62.931% |
TCI GENE Inc. | 10.04 Million TWD | 725.465% |
MegaPro Biomedical Co., Ltd | -127.25 Million TWD | 50.609% |
Senhwa Biosciences, Inc. | -311.11 Million TWD | 79.797% |
Taiwan Bio Therapeutics Co., Ltd | -212.2 Million TWD | 70.381% |
NatureWise Biotech & Medicals Corporation | 3.43 Million TWD | 1930.315% |
PharmaEngine, Inc. | 277.18 Million TWD | 122.676% |
Savior Lifetec Corporation | -2.42 Million TWD | -2497.231% |
TaiGen Biopharmaceuticals Holdings Limited | -174.69 Million TWD | 64.022% |
Meribank Biotech Co., Ltd | -123.15 Million TWD | 48.964% |
Acepodia, Inc. | -435.97 Million TWD | 85.583% |
Caliway Biopharmaceuticals Co., Ltd. | -487.95 Million TWD | 87.119% |